Revised Tracleer labelling in US due to hepatotoxicity reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1092, 2006-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zafirlukast labelling revised in the US

By  

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Revised safety labelling for zanamivir in the US

By  

Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

By  

Reactions Weekly, Vol. 1, Iss. 1132, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Revised labelling for Adderall XR in Canada

By  

Reactions Weekly, Vol. 1, Iss. 1068, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite